home / stock / mreo / mreo news

MREO News and Press, Mereo BioPharma Group From 08/25/20

Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...
MREO - RIG, GPS among premarket gainers

Urban One (NASDAQ: UONE ) +85% . More news on: Urban One, Inc., Ovid Therapeutics Inc., RealNetworks, Inc., Stocks on the move, , Read more ...

MREO - Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease

LONDON and REDWOOD CITY, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced the initiation of a ...

MREO - IPO Update: iTeos Therapeutics Finalizes IPO Plan

Quick Take iTeos Therapeutics ( ITOS ) intends to raise $151 million from the sale of its common stock in an IPO, according to an amended registration statement . The company is developing a range of treatments for various cancers, including solid tumors. ITOS is pursuing treatments for...

MREO - iTeos Therapeutics Begins U.S. IPO Rollout

Quick Take iTeos Therapeutics ( ITOS ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The company is a clinical stage biopharma firm advancing a pipeline of immuno-oncology drug candidates for treating solid tumors and other can...
MREO - Mereo BioPharma Strengthens Management Team; Appoints John Lewicki, PhD, as Chief Scientific Officer and Ann Kapoun, PhD, as SVP of Translational Research and Development

LONDON and REDWOOD CITY, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced the appointments of ...

MREO - Mereo BioPharma reports FY results

Mereo BioPharma Group (NASDAQ: MREO ): FY GAAP EPS of £35.3M Cash resources of £16.3M Press Release More news on: Mereo BioPharma Group plc, Earnings news and commentary, Healthcare stocks news, ,

MREO - Mereo BioPharma Announces Financial Results for the Year Ended December 31, 2019

LONDON and REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced financial results fo...
MREO - WORK, PD among premarket losers

Cinedigm (NASDAQ: CIDM ) -24% . More news on: Cinedigm Corp., Dolphin Entertainment, Inc., Titan Medical Inc., Stocks on the move, , Read more ...

MREO - AAL, LK, SMAR and SAVA among midday movers

Gainers: Vislink Technologies (NASDAQ: VISL )  +174% . More news on: Vislink Technologies, Inc., Cinedigm Corp., Kezar Life Sciences, Inc., Stocks on the move, , Read more ...

MREO - Mereo Bio completes $70M private placement; advances etigilimab into Phase 1b study

Mereo BioPharma ( MREO +56.9% ) has completed $70M (£56M) private placement (the “Fundraising”). More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move, Read more ...

Previous 10 Next 10